This statistic shows the operating expenses of Danish biotechnology company Genmab from 2017 to 2024. From 2017 onwards, the company reported increasing operating expenses. The amount peaked in 2024, at around 14.8 billion Danish kroner. Genmab is a Danish biotechnology company founded in 1999. The company is specializing in therapeutics for cancer treatment.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Genmab, & Nasdaq Nordic. (February 12, 2025). Operating expenses of Genmab from 2017 to 2024 (in million DKK) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 22, 2026, from /statistics/970445/operating-expenses-of-genmab/
Genmab, und Nasdaq Nordic. "Operating expenses of Genmab from 2017 to 2024 (in million DKK) ." Chart. February 12, 2025. ÌÇÐÄÆƽâ°æ. Accessed July 22, 2026. /statistics/970445/operating-expenses-of-genmab/
Genmab, Nasdaq Nordic. (2025). Operating expenses of Genmab from 2017 to 2024 (in million DKK) . ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 22, 2026. /statistics/970445/operating-expenses-of-genmab/
Genmab, and Nasdaq Nordic. "Operating Expenses of Genmab from 2017 to 2024 (in Million Dkk) ." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 12 Feb 2025, /statistics/970445/operating-expenses-of-genmab/
Genmab & Nasdaq Nordic, Operating expenses of Genmab from 2017 to 2024 (in million DKK) ÌÇÐÄÆƽâ°æ, /statistics/970445/operating-expenses-of-genmab/ (last visited July 22, 2026)
Operating expenses of Genmab from 2017 to 2024 (in million DKK) [Graph], Genmab, & Nasdaq Nordic, February 12, 2025. [Online]. Available: /statistics/970445/operating-expenses-of-genmab/
